Investor Relations

Press Release

May 3, 2023

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023

More
April 24, 2023

Lilly to Divest BAQSIMI to Amphastar

More
April 24, 2023

Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023

More
April 12, 2023

Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

More
March 8, 2023

Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg

More
February 28, 2023

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022

More
February 22, 2023

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023

More
November 22, 2022

Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference

More
November 10, 2022

Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference

More
November 7, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022

More
Youtube